StockData
Verrica Pharmaceuticals Inc. logo

Verrica Pharmaceuticals Inc. (VRCA) stock

VRCANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$3.20−0.36 (-10.11%)

Close on Nov 16, 2026Market cap $54.97MP/E –Yield –

Verrica Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Verrica Pharmaceuticals's total assets was $36.02M at Jun 30, 2026. For fiscal 2025 it was $47.13M, down 12.9% from the year before. The highest annual figure on record is $91.91M in fiscal 2018.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$47.13M-12.9%
FY2024Dec 31, 2024$54.13M-33.7%
FY2023Dec 31, 2023$81.60M+82.5%
FY2022Dec 31, 2022$44.72M-44.2%
FY2021Dec 31, 2021$80.13M+8.1%
FY2020Dec 31, 2020$74.15M+8.4%
FY2019Dec 31, 2019$68.42M-25.6%
FY2018Dec 31, 2018$91.91M+911.8%
FY2017Dec 31, 2017$9.08M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$36.02M-7.9%
Q1 FY2026Mar 31, 2026$38.79M-8.0%
Q4 FY2025Dec 31, 2025$47.13M-12.9%
Q3 FY2025Sep 30, 2025$40.90M+24.2%
Q2 FY2025Jun 30, 2025$39.11M-24.8%
Q1 FY2025Mar 31, 2025$42.18M-36.4%
Q4 FY2024Dec 31, 2024$54.13M-33.7%
Q3 FY2024Sep 30, 2024$32.93M-66.1%
Q2 FY2024Jun 30, 2024$52.01M-16.4%
Q1 FY2024Mar 31, 2024$66.31M-3.4%
Q4 FY2023Dec 31, 2023$81.60M+82.5%
Q3 FY2023Sep 30, 2023$97.15M+97.7%
Q2 FY2023Jun 30, 2023$62.20M-1.9%
Q1 FY2023Mar 31, 2023$68.64M-4.2%
Q4 FY2022Dec 31, 2022$44.72M-44.2%
Q3 FY2022Sep 30, 2022$49.15M-44.6%
Q2 FY2022Jun 30, 2022$63.44M-35.9%
Q1 FY2022Mar 31, 2022$71.62M-33.8%
Q4 FY2021Dec 31, 2021$80.13M+8.1%
Q3 FY2021Sep 30, 2021$88.76M+11.0%
Q2 FY2021Jun 30, 2021$99.03M+13.5%
Q1 FY2021Mar 31, 2021$108.10M+14.5%
Q4 FY2020Dec 31, 2020$74.15M+8.4%
Q3 FY2020Sep 30, 2020$79.94M+5.1%
Q2 FY2020Jun 30, 2020$87.24M+7.4%
Q1 FY2020Mar 31, 2020$94.44M+9.8%
Q4 FY2019Dec 31, 2019$68.42M-25.6%
Q3 FY2019Sep 30, 2019$76.07M-23.0%
Q2 FY2019Jun 30, 2019$81.25M-22.4%
Q1 FY2019Mar 31, 2019$85.98M+846.6%
Q4 FY2018Dec 31, 2018$91.91M–
Q3 FY2018Sep 30, 2018$98.81M–
Q2 FY2018Jun 30, 2018$104.72M–
Q4 FY2017Dec 31, 2017$9.08M–

More Verrica Pharmaceuticals figures

See a number that looks wrong?